Filing Details
- Accession Number:
- 0001209191-15-002633
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-06 21:20:22
- Reporting Period:
- 2015-01-06
- Filing Date:
- 2015-01-06
- Accepted Time:
- 2015-01-06 21:20:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1522602 | Cohbar Inc. | COB.U:TSXV | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1628067 | Leland Jon Stern | Po Box 955 Mill Valley CA 94942 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-01-06 | 300,000 | $0.00 | 300,000 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2015-01-06 | 150,000 | $0.00 | 450,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Convertible Preferred Stock | Disposition | 2015-01-06 | 300,000 | $0.00 | 300,000 | $0.00 |
Common Stock | Warrants (right to buy) | Acquisiton | 2015-01-06 | 75,000 | $0.00 | 75,000 | $2.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
75,000 | 2015-01-06 | 2017-01-06 | No | 4 | P | Direct |
Footnotes
- The Series B Convertible Preferred Stock converted into common stock on a one-for-one basis and had no expiration date.
- The reported securities are included within 150,000 units purchased by the reporting person for $1.00 per unit. Each unit consists of one share of common stock and one half of one common stock purchase warrant.